SRPT Financials
Sarepta Therapeutics Inc - Financial statements & key metrics
Stock Price
$20.76
Market Cap
$2.34B
P/E Ratio
8.4
EPS
$2.47
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.90B
Gross Profit
-
Operating Income
-
Net Income
$235.24M
EPS (Diluted)
$2.34
Balance Sheet Highlights
Total Assets
$3.96B
Total Liabilities
$2.44B
Shareholders Equity
-
Cash & Equivalents
$1.10B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-205.79M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
12.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SRPT revenue?
SRPT's most recent quarterly revenue was $1.90B. Annual revenue can be calculated by summing the four most recent quarters.
Is SRPT profitable?
SRPT reported a profit of $235.24M in the most recent quarter. The net profit margin is 12.4%.
What is SRPT market cap?
SRPT has a market capitalization of $2.34B, making it a mid-cap stock.
Does SRPT have debt?
View SRPT's balance sheet for debt information.
What is SRPT cash flow?
Cash flow data is available in the full financial statements.